Freshfields advised Roivant in sale of Dermavant to Organon. Organon & Co. has announced the acquisition of Dermavant Sciences Ltd., a subsidiary of Roivant Sciences Ltd.,...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell and Conyers Dill & Pearman advised Roivant Sciences Ltd. on the offering. Cooley advised Immunovant on the transaction. Roivant Sciences Ltd. (Nasdaq:ROIV)...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell represented Roivant Sciences, while Latham & Watkins represented the underwriters in the offering. Roivant Sciences (Nasdaq: ROIV) has announced its $230 million...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Roivant Sciences Ltd. in the deal, while Covington represented the underwriter, Cantor Fitzgerald. Roivant Sciences Ltd. announced its debut SEC-registered offering of 30,000,000...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Roivant Sciences Ltd. in the offering. Roivant Sciences Ltd. announced its at-the-market offering program under which Roivant may issue and sell its common shares...
You must be a Standard 1 Year member to access this content.
Conyers and Davis Polk & Wardwell is advising Roivant Sciences Ltd., in its business combination by merger of a subsidiary with Montes Archimedes Acquisition Corp. (MAAC)...
You must be a Standard 1 Year member to access this content.
